Clinical Trials Browser

Phase 1 × INDUSTRY × surufatinib × Clear all

NCT04427774 2021-07-20

A Study of Surufatinib Plus Sintilimab in Patients With Advanced Solid Tumor

Phase 1 Terminated

Other solid neoplasm

Advanced or Metastatic Solid Tumors

NCT02133157 2020-07-08

HMPL

Phase 1 Completed

Neoplasms

NCT02267967 2018-11-13

Phase Ib/II Study of Sulfatinib in Treating Advanced Neuroendocrine Tumors

Phase 1 Completed

Neuroendocrine Tumors